Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9305fc720f87097494d965f1b1310e24 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-314 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
filingDate |
2017-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27b8324b65afcc6005823a5ca0126f87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb4ddfb5c62ebd6ef1e6fc99950d8726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63a3ec1da134970e66a695c128c8928b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75e4675f9eae4e85b970eec5d101ba28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c859a4df90e7b5630f441bdff7e93e45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8134eb83f5a3a50ec544c98c572b3992 |
publicationDate |
2018-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20180044185-A |
titleOfInvention |
Pharmaceutical composition for prevention or treatment of pneumonia comprising quinolin 4-one derivative or pharmacurically acceptable salt thereof as an active ingredient |
abstract |
The present invention relates to a quinolinone 4-one derivative, a pharmaceutically acceptable salt thereof, or a pharmaceutical composition for preventing or treating pneumonia comprising as an active ingredient thereof. The quinolinone 4-one derivative according to the present invention not only has an excellent antibacterial activity but also has excellent antimicrobial activity against pneumococci having resistance to drugs, unlike the conventional antimicrobial agents, so that the prevention or prevention of pneumonia caused by these pneumococci And can be usefully used as a therapeutic pharmaceutical composition. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200042586-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020080682-A1 |
priorityDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |